nodes	percent_of_prediction	percent_of_DWPC	metapath
Procyclidine—CHRM4—nervous system—attention deficit hyperactivity disorder	0.0094	0.0909	CbGeAlD
Procyclidine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00929	0.0898	CbGeAlD
Procyclidine—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.00905	0.0875	CbGeAlD
Procyclidine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00845	0.0817	CbGeAlD
Procyclidine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00785	0.0759	CbGeAlD
Procyclidine—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00757	0.0731	CbGeAlD
Procyclidine—CHRM4—brain—attention deficit hyperactivity disorder	0.00718	0.0695	CbGeAlD
Procyclidine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00715	0.0691	CbGeAlD
Procyclidine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00504	0.0487	CbGeAlD
Procyclidine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00485	0.0469	CbGeAlD
Procyclidine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00459	0.0444	CbGeAlD
Procyclidine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00442	0.0427	CbGeAlD
Procyclidine—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00411	0.0397	CbGeAlD
Procyclidine—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00395	0.0382	CbGeAlD
Procyclidine—CHRM2—brain—attention deficit hyperactivity disorder	0.00385	0.0373	CbGeAlD
Procyclidine—CHRM1—brain—attention deficit hyperactivity disorder	0.00351	0.0339	CbGeAlD
Procyclidine—CHRM3—brain—attention deficit hyperactivity disorder	0.00314	0.0304	CbGeAlD
Procyclidine—CHRM1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.0014	0.00156	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00139	0.00155	CbGpPWpGaD
Procyclidine—CHRM1—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00138	0.00154	CbGpPWpGaD
Procyclidine—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00138	0.00154	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00138	0.00154	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00134	0.0015	CbGpPWpGaD
Procyclidine—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00134	0.00149	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.0013	0.00145	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00129	0.00144	CbGpPWpGaD
Procyclidine—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00129	0.00144	CbGpPWpGaD
Procyclidine—CHRM1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00129	0.00144	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00128	0.00143	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00127	0.00142	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00127	0.00141	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00125	0.0014	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00125	0.0014	CbGpPWpGaD
Procyclidine—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00124	0.00139	CbGpPWpGaD
Procyclidine—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00122	0.00136	CbGpPWpGaD
Procyclidine—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00121	0.00134	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00121	0.00134	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.0012	0.00134	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0012	0.00134	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0012	0.00134	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00119	0.00133	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00119	0.00133	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00119	0.00132	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00117	0.00131	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00117	0.0013	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00117	0.0013	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00116	0.0013	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00115	0.00129	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00115	0.00128	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00114	0.00128	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00113	0.00126	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00113	0.00126	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00113	0.00126	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00113	0.00126	CbGpPWpGaD
Procyclidine—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00112	0.00125	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00112	0.00125	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00111	0.00124	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00111	0.00124	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00111	0.00124	CbGpPWpGaD
Procyclidine—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0011	0.00122	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0011	0.00122	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.0011	0.00122	CbGpPWpGaD
Procyclidine—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00109	0.00122	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00109	0.00122	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00109	0.00121	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00108	0.00121	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00108	0.0012	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00106	0.00119	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00106	0.00118	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00105	0.00117	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00104	0.00116	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00103	0.00115	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00103	0.00115	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00102	0.00114	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00102	0.00114	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.001	0.00112	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000997	0.00111	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000988	0.0011	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000983	0.0011	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00098	0.00109	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000971	0.00108	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000971	0.00108	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000968	0.00108	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000968	0.00108	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000965	0.00108	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000959	0.00107	CbGpPWpGaD
Procyclidine—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000957	0.00107	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000956	0.00107	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000956	0.00107	CbGpPWpGaD
Procyclidine—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000954	0.00106	CbGpPWpGaD
Procyclidine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00094	0.00105	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000905	0.00101	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000902	0.00101	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000893	0.000996	CbGpPWpGaD
Procyclidine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000856	0.000954	CbGpPWpGaD
Procyclidine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000853	0.000951	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000846	0.000944	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000843	0.000941	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000835	0.000932	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000811	0.000905	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000806	0.000899	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000803	0.000896	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000795	0.000887	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000789	0.00088	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000787	0.000877	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000787	0.000877	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000784	0.000875	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000779	0.000869	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000776	0.000866	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000762	0.00085	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000759	0.000847	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000752	0.000839	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000749	0.000835	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000746	0.000833	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000746	0.000832	CbGpPWpGaD
Procyclidine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00074	0.000825	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00074	0.000825	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000739	0.000824	CbGpPWpGaD
Procyclidine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000737	0.000822	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000737	0.000822	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000737	0.000822	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000732	0.000816	CbGpPWpGaD
Procyclidine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00073	0.000814	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00073	0.000814	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000729	0.000813	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000722	0.000805	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000717	0.000799	CbGpPWpGaD
Procyclidine—CHRM4—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000716	0.000798	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000714	0.000797	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000709	0.000791	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000707	0.000789	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000689	0.000768	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000687	0.000766	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00068	0.000759	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000659	0.000735	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000644	0.000719	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000644	0.000718	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000642	0.000716	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000641	0.000715	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000638	0.000712	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000636	0.000709	CbGpPWpGaD
Procyclidine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000634	0.000707	CbGpPWpGaD
Procyclidine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000632	0.000705	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000628	0.0007	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000628	0.0007	CbGpPWpGaD
Procyclidine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000626	0.000698	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00062	0.000691	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000616	0.000687	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000599	0.000668	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00058	0.000647	CbGpPWpGaD
Procyclidine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000578	0.000645	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000577	0.000644	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00057	0.000636	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000563	0.000628	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000547	0.00061	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000545	0.000608	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00054	0.000602	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000524	0.000585	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000515	0.000575	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000503	0.000561	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000501	0.000559	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000497	0.000554	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000497	0.000554	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000495	0.000552	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00049	0.000547	CbGpPWpGaD
Procyclidine—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000483	0.000538	CbGpPWpGaD
Procyclidine—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000481	0.000536	CbGpPWpGaD
Procyclidine—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000478	0.000534	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000478	0.000533	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000477	0.000532	CbGpPWpGaD
Procyclidine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000476	0.000531	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000472	0.000526	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000445	0.000496	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000443	0.000494	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000439	0.000489	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000435	0.000485	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000434	0.000484	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000433	0.000483	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000432	0.000482	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000431	0.00048	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000431	0.00048	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000429	0.000479	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000429	0.000478	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000427	0.000476	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000425	0.000474	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000423	0.000472	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000423	0.000472	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000422	0.000471	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000422	0.00047	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000418	0.000466	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000418	0.000466	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000418	0.000466	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000417	0.000465	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000415	0.000463	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000414	0.000462	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000413	0.00046	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00041	0.000457	CbGpPWpGaD
Procyclidine—CHRM4—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000404	0.000451	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000404	0.00045	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000402	0.000449	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000398	0.000444	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000391	0.000436	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00039	0.000435	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000389	0.000434	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000388	0.000433	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000386	0.00043	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000384	0.000429	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000384	0.000429	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000383	0.000427	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00038	0.000424	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00038	0.000423	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000379	0.000423	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000378	0.000422	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000375	0.000418	CbGpPWpGaD
Procyclidine—CHRM4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000367	0.00041	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000356	0.000397	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000356	0.000397	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000354	0.000394	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000354	0.000394	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000352	0.000393	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00035	0.00039	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000349	0.000389	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000343	0.000382	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000337	0.000376	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000333	0.000371	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000325	0.000363	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00031	0.000345	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000293	0.000327	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000293	0.000326	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00029	0.000323	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000284	0.000317	CbGpPWpGaD
Procyclidine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000273	0.000304	CbGpPWpGaD
Procyclidine—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000272	0.000303	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000271	0.000302	CbGpPWpGaD
Procyclidine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000269	0.0003	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000257	0.000286	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000256	0.000285	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000253	0.000282	CbGpPWpGaD
Procyclidine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000248	0.000276	CbGpPWpGaD
Procyclidine—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000247	0.000275	CbGpPWpGaD
Procyclidine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000244	0.000273	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000238	0.000266	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000238	0.000265	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000235	0.000263	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000231	0.000258	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00023	0.000257	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000228	0.000254	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000227	0.000253	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000226	0.000252	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000224	0.00025	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000224	0.00025	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000223	0.000249	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000221	0.000247	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000217	0.000242	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000215	0.00024	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000214	0.000239	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000209	0.000233	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000208	0.000232	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000206	0.00023	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000146	0.000163	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000146	0.000163	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000144	0.000161	CbGpPWpGaD
Procyclidine—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000115	0.000128	CbGpPWpGaD
Procyclidine—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	9.24e-05	0.000103	CbGpPWpGaD
Procyclidine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.75e-05	8.64e-05	CbGpPWpGaD
Procyclidine—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.73e-05	8.62e-05	CbGpPWpGaD
Procyclidine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.65e-05	8.53e-05	CbGpPWpGaD
